siRNA therapy lowers triglycerides in patients along with rare condition

.RESEARCH EMPHASIZE.19 September 2024.

Plozasiran decreased triglyceride levels through 80% and also decreased the risk of pancreatitis in patients with consistent chylomicronemia, with or even without a hereditary prognosis.